1287220-79-4

Upstream product

• 1287220-82-9 tert-butyl 4-{[4-chloro-6-(2,2,2-trifluoroethoxy)-1,3,5-triazin-2-yl]amino}benzoate 
• 546115-65-5 1-(3-bromophenyl)cyclopropan-1-amine 
• 68076-36-8 1-amino-4-[(tert-butyloxycarbonyl)amino]butane 
• 1287220-78-3 tert-butyl 4-(4-(1-(3-bromophenyl)cyclopropylamino)-6-(2,2,2-trifluoroethoxy)-1,3,5-triazin-2-ylamino)benzoate 
• 185677-00-3 2,4-dichloro-6-(2,2,2-trifluoroethoxy)-1,3,5-triazine 
• 18144-47-3 tert-butyl 4-aminobenzoate 

Relevant academic research and scientific papers

COMPOUNDS FOR THE TREATMENT OF HEPATITIS C

The disclosure provides compounds of formula I, including pharmaceutically acceptable salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.

COMPOUNDS FOR THE TREATMENT OF HEPATITIS C

The disclosure provides compounds of formula I, including pharmaceutically acceptable salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV